Manganese dioxide has been widely recognized as catalyst in catalytic ozonation for organic pollutants removal from wastewater in recent decades. However, few studies focus on the structure-activity relationship of MnO2 and catalytic ozonation mechanism in water. In the present study, the oxidative reactivity of three different crystal phases of MnO2 corresponding to α-MnO2, β-MnO2 and γ-MnO2 towards metoprolol (MET) and ibuprofen (IBU) were evaluated. α-MnO2 was found to contain the most abundant oxygen vacancy and readily reducible surface adsorbed oxygen (O2-, O-, OH-), which facilitated an increase of ozone utilization and the highest catalytic performance with 99% degradation efficiency for IBU and MET. α-MnO2 was then selected to investigate the optimum key operating parameters with a result of catalyst dosage 0.1 g/L, ozone dosage 1 mg/min and an initial pH 7. The introduction of α-MnO2 promoted reactive oxygen species (O2-, O-, OH-) generation which played significant roles in IBU degradation. Probable degradation pathways of MET and IBU were proposed according to the organic intermediates identified and the reaction sites based on density function theory (DFT) calculations. The present study deepened our understanding on the MnO2 catalyzed ozonation and provided reference to enhance the process efficiency.
Keywords: Catalytic ozonation; MnO(2); Oxygen vacancy; Pharmaceuticals degradation.
Copyright © 2021 Elsevier B.V. All rights reserved.